M. Rogers

1.1k total citations
10 papers, 918 citations indexed

About

M. Rogers is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, M. Rogers has authored 10 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in M. Rogers's work include Immunotherapy and Immune Responses (10 papers), vaccines and immunoinformatics approaches (7 papers) and T-cell and B-cell Immunology (3 papers). M. Rogers is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), vaccines and immunoinformatics approaches (7 papers) and T-cell and B-cell Immunology (3 papers). M. Rogers collaborates with scholars based in United States. M. Rogers's co-authors include Gerald M. Kenny, S.J. Simmons, B.A. Tjoa, G.P. Murphy, Alton L. Boynton, Haakon Ragde, M.J. Troychak, A. Elgamal, Michael L. Salgaller and Oliver E. Cobb and has published in prestigious journals such as The Prostate.

In The Last Decade

M. Rogers

10 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Rogers United States 9 797 431 416 124 70 10 918
S.J. Simmons United States 9 717 0.9× 394 0.9× 393 0.9× 144 1.2× 66 0.9× 10 862
A. Elgamal United States 8 662 0.8× 357 0.8× 341 0.8× 121 1.0× 55 0.8× 10 784
M.J. Troychak United States 10 786 1.0× 423 1.0× 439 1.1× 260 2.1× 69 1.0× 13 1.0k
Jeff Schlom United States 3 396 0.5× 318 0.7× 180 0.4× 151 1.2× 69 1.0× 4 590
Jolie Snively United States 7 630 0.8× 682 1.6× 276 0.7× 71 0.6× 49 0.7× 8 934
J. J. Mahany United States 9 487 0.6× 541 1.3× 205 0.5× 88 0.7× 39 0.6× 22 766
Elizabeth Seja United States 10 682 0.9× 770 1.8× 206 0.5× 73 0.6× 42 0.6× 12 963
Christine Hanlon United States 5 403 0.5× 409 0.9× 347 0.8× 60 0.5× 31 0.4× 5 758
Matthias Krusch Germany 15 992 1.2× 536 1.2× 261 0.6× 49 0.4× 29 0.4× 27 1.3k
Aurélie Durgeau France 7 776 1.0× 661 1.5× 181 0.4× 89 0.7× 33 0.5× 7 1.0k

Countries citing papers authored by M. Rogers

Since Specialization
Citations

This map shows the geographic impact of M. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rogers more than expected).

Fields of papers citing papers by M. Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rogers. The network helps show where M. Rogers may publish in the future.

Co-authorship network of co-authors of M. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rogers. A scholar is included among the top collaborators of M. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rogers. M. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Simmons, S.J., B.A. Tjoa, M. Rogers, et al.. (1999). GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial. The Prostate. 39(4). 291–297. 59 indexed citations
4.
Tjoa, B.A., S.J. Simmons, A. Elgamal, et al.. (1999). Follow-up evaluation of a phase II prostate cancer vaccine trial. The Prostate. 40(2). 125–129. 121 indexed citations
5.
6.
Murphy, G.P., B.A. Tjoa, S.J. Simmons, et al.. (1999). Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment. The Prostate. 39(1). 54–59. 153 indexed citations
7.
Tjoa, B.A., S.J. Simmons, A. Elgamal, et al.. (1999). Follow‐up evaluation of a phase II prostate cancer vaccine trial. The Prostate. 40(2). 125–129. 9 indexed citations
8.
Murphy, G.P., B.A. Tjoa, S.J. Simmons, et al.. (1999). Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment. The Prostate. 39(1). 54–59. 7 indexed citations
9.
Tjoa, B.A., S.J. Simmons, Victoria Bowes, et al.. (1998). Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. The Prostate. 36(1). 39–44. 207 indexed citations
10.
Salgaller, Michael L., Patricia A. Lodge, Douglas J. Loftus, et al.. (1998). Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA). The Prostate. 35(2). 144–151. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.J. Simmons Breakdown of academic impact, for papers by A. Elgamal Breakdown of academic impact, for papers by M.J. Troychak Breakdown of academic impact, for papers by Jeff Schlom Breakdown of academic impact, for papers by Jolie Snively Breakdown of academic impact, for papers by J. J. Mahany Breakdown of academic impact, for papers by Elizabeth Seja Breakdown of academic impact, for papers by Christine Hanlon Breakdown of academic impact, for papers by Matthias Krusch Breakdown of academic impact, for papers by Aurélie Durgeau
Rankless by CCL
2026